178 related articles for article (PubMed ID: 21674808)
1. Apoptosis inhibitors and mini-agrin have additive benefits in congenital muscular dystrophy mice.
Meinen S; Lin S; Thurnherr R; Erb M; Meier T; Rüegg MA
EMBO Mol Med; 2011 Aug; 3(8):465-79. PubMed ID: 21674808
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of mini-agrin in skeletal muscle increases muscle integrity and regenerative capacity in laminin-alpha2-deficient mice.
Bentzinger CF; Barzaghi P; Lin S; Ruegg MA
FASEB J; 2005 Jun; 19(8):934-42. PubMed ID: 15923403
[TBL] [Abstract][Full Text] [Related]
3. Linker molecules between laminins and dystroglycan ameliorate laminin-alpha2-deficient muscular dystrophy at all disease stages.
Meinen S; Barzaghi P; Lin S; Lochmüller H; Ruegg MA
J Cell Biol; 2007 Mar; 176(7):979-93. PubMed ID: 17389231
[TBL] [Abstract][Full Text] [Related]
4. Autophagy is increased in laminin α2 chain-deficient muscle and its inhibition improves muscle morphology in a mouse model of MDC1A.
Carmignac V; Svensson M; Körner Z; Elowsson L; Matsumura C; Gawlik KI; Allamand V; Durbeej M
Hum Mol Genet; 2011 Dec; 20(24):4891-902. PubMed ID: 21920942
[TBL] [Abstract][Full Text] [Related]
5. An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophy.
Moll J; Barzaghi P; Lin S; Bezakova G; Lochmüller H; Engvall E; Müller U; Ruegg MA
Nature; 2001 Sep; 413(6853):302-7. PubMed ID: 11565031
[TBL] [Abstract][Full Text] [Related]
6. Omigapil treatment decreases fibrosis and improves respiratory rate in dy(2J) mouse model of congenital muscular dystrophy.
Yu Q; Sali A; Van der Meulen J; Creeden BK; Gordish-Dressman H; Rutkowski A; Rayavarapu S; Uaesoontrachoon K; Huynh T; Nagaraju K; Spurney CF
PLoS One; 2013; 8(6):e65468. PubMed ID: 23762378
[TBL] [Abstract][Full Text] [Related]
7. Muscle-specific BCL2 expression ameliorates muscle disease in laminin {alpha}2-deficient, but not in dystrophin-deficient, mice.
Dominov JA; Kravetz AJ; Ardelt M; Kostek CA; Beermann ML; Miller JB
Hum Mol Genet; 2005 Apr; 14(8):1029-40. PubMed ID: 15757977
[TBL] [Abstract][Full Text] [Related]
8. Omigapil ameliorates the pathology of muscle dystrophy caused by laminin-alpha2 deficiency.
Erb M; Meinen S; Barzaghi P; Sumanovski LT; Courdier-Früh I; Rüegg MA; Meier T
J Pharmacol Exp Ther; 2009 Dec; 331(3):787-95. PubMed ID: 19759319
[TBL] [Abstract][Full Text] [Related]
9. Laminin-111 protein therapy reduces muscle pathology and improves viability of a mouse model of merosin-deficient congenital muscular dystrophy.
Rooney JE; Knapp JR; Hodges BL; Wuebbles RD; Burkin DJ
Am J Pathol; 2012 Apr; 180(4):1593-602. PubMed ID: 22322301
[TBL] [Abstract][Full Text] [Related]
10. Expression of mouse agrin in normal, denervated and dystrophic muscle.
Eusebio A; Oliveri F; Barzaghi P; Ruegg MA
Neuromuscul Disord; 2003 Jun; 13(5):408-15. PubMed ID: 12798796
[TBL] [Abstract][Full Text] [Related]
11. Transgenic overexpression of the α7 integrin reduces muscle pathology and improves viability in the dy(W) mouse model of merosin-deficient congenital muscular dystrophy type 1A.
Doe JA; Wuebbles RD; Allred ET; Rooney JE; Elorza M; Burkin DJ
J Cell Sci; 2011 Jul; 124(Pt 13):2287-97. PubMed ID: 21652631
[TBL] [Abstract][Full Text] [Related]
12. Linker proteins restore basement membrane and correct
Reinhard JR; Lin S; McKee KK; Meinen S; Crosson SC; Sury M; Hobbs S; Maier G; Yurchenco PD; Rüegg MA
Sci Transl Med; 2017 Jun; 9(396):. PubMed ID: 28659438
[No Abstract] [Full Text] [Related]
13. Overexpression of the cytotoxic T cell (CT) carbohydrate inhibits muscular dystrophy in the dyW mouse model of congenital muscular dystrophy 1A.
Xu R; Chandrasekharan K; Yoon JH; Camboni M; Martin PT
Am J Pathol; 2007 Jul; 171(1):181-99. PubMed ID: 17591965
[TBL] [Abstract][Full Text] [Related]
14. Amelioration of Muscle and Nerve Pathology in LAMA2 Muscular Dystrophy by AAV9-Mini-Agrin.
Qiao C; Dai Y; Nikolova VD; Jin Q; Li J; Xiao B; Li J; Moy SS; Xiao X
Mol Ther Methods Clin Dev; 2018 Jun; 9():47-56. PubMed ID: 29766020
[TBL] [Abstract][Full Text] [Related]
15. Adeno-Associated Virus-Mediated Mini-Agrin Delivery Is Unable to Rescue Disease Phenotype in a Mouse Model of Limb Girdle Muscular Dystrophy Type 2I.
Vannoy CH; Zhou H; Qiao C; Xiao X; Bang AG; Lu QL
Am J Pathol; 2017 Feb; 187(2):431-440. PubMed ID: 28107841
[TBL] [Abstract][Full Text] [Related]
16. Triggering regeneration and tackling apoptosis: a combinatorial approach to treating congenital muscular dystrophy type 1 A.
Yamauchi J; Kumar A; Duarte L; Mehuron T; Girgenrath M
Hum Mol Genet; 2013 Nov; 22(21):4306-17. PubMed ID: 23773998
[TBL] [Abstract][Full Text] [Related]
17. Muscle-specific expression of insulin-like growth factor 1 improves outcome in Lama2Dy-w mice, a model for congenital muscular dystrophy type 1A.
Kumar A; Yamauchi J; Girgenrath T; Girgenrath M
Hum Mol Genet; 2011 Jun; 20(12):2333-43. PubMed ID: 21441569
[TBL] [Abstract][Full Text] [Related]
18. Nerve pathology is prevented by linker proteins in mouse models for
Reinhard JR; Porrello E; Lin S; Pelczar P; Previtali SC; Rüegg MA
PNAS Nexus; 2023 Apr; 2(4):pgad083. PubMed ID: 37038437
[No Abstract] [Full Text] [Related]
19. Early skeletal muscle pathology and disease progress in the dy
Gawlik KI; Körner Z; Oliveira BM; Durbeej M
Sci Rep; 2019 Oct; 9(1):14324. PubMed ID: 31586140
[TBL] [Abstract][Full Text] [Related]
20. Expression profiling of muscles from Fukuyama-type congenital muscular dystrophy and laminin-alpha 2 deficient congenital muscular dystrophy; is congenital muscular dystrophy a primary fibrotic disease?
Taniguchi M; Kurahashi H; Noguchi S; Sese J; Okinaga T; Tsukahara T; Guicheney P; Ozono K; Nishino I; Morishita S; Toda T
Biochem Biophys Res Commun; 2006 Apr; 342(2):489-502. PubMed ID: 16487936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
